UPDATE 1-Supernus Pharma's ADHD treatment meets main goal in two studies
December 06, 2018 at 07:34 AM EST
Supernus Pharmaceuticals Inc on Thursday said its experimental treatment for attention deficit hyperactivity disorder (ADHD) met the main goal of reducing disorder symptoms in children in two late-stage studies.